Progentec Diagnostics Inc. launched a novel blood test to determine the likelihood that a patient with systemic lupus erythematosus (commonly known as both SLE and lupus) will experience an immunologic disease flare during the coming 12 weeks.
MJH Life Sciences™ Launches COVID-19 Coalition — Alliance of renowned thought leaders to assemble biweekly to keep health care professionals abreast of emerging COVID-19 science and news. […]
Fingerpaint, a full-service health and wellness marketing agency with five offices across the United States and almost $80 million in revenue, announced the creation of the SHIFT Performance Center of Excellence and the launch of its proprietary Actionable Intelligence Engine.
Clinical diagnostics company Novacyt, one of many healthcare companies whose shares have surged during the pandemic, launched a test to differentiate between Covid-19 and common winter diseases.
ATAI Life Sciences launched EmpathBio, a wholly owned subsidiary focused on developing derivatives of 3,4-methylenedioxy-methamphetamine for the treatment of post-traumatic stress disorder (PTSD).
Shares of Cambridge, Mass.-based Biogen were down after Mylan announced the launch of the first generic version of the top-selling multiple sclerosis drug Tecfidera.
North Dakota, Wyoming and Alabama are the latest U.S. states launching apps to warn users about potential exposure to the novel coronavirus by tracking their encounters, representatives for the states told Reuters.
Independent, full-service talent acquisition and development firm Global Talent Vision LLC launched, managed and directed by pharmaceutical and healthcare communications industry Matthew West.
One small pharma company is meeting the challenge of COVID-19 by finding new ways to support the practices of its specialist physician customers.
ARC Therapeutics launched with a $6 million financing led by founding investor Eshelman Ventures LLC.
